Clinical Trial Update: Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the pharmacokinetics of 48 hours of sevoflurane inhalation delivered via the AnaConDa disposable system in obese ICU patients. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Sevoflurane (Sevoflurane)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Obesity | Phase 2 | Status: COMPLETED